Igenica Raises $24 Million
Igenica Inc., a developer of antibody-based cancer medicines, has raised $24 million in Series B funding. Return backers include The Column Group, OrbiMed Advisors and 5AM Ventures. The Burlingame, Calif.-based company previously raised just over $5 million.
11 June 2010•2 mins read
